BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27477214)

  • 1. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Ananworanich J; Puthanakit T;
    Antivir Ther; 2017; 22(6):471-479. PubMed ID: 27786155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Ananworanich J; Puthanakit T;
    AIDS; 2016 Apr; 30(7):1059-67. PubMed ID: 26807972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T; Saksawad R; Bunupuradah T; Wittawatmongkol O; Chuanjaroen T; Ubolyam S; Chaiwatanarat T; Nakavachara P; Maleesatharn A; Chokephaibulkit K
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):477-83. PubMed ID: 22918157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
    Rukuni R; Rehman AM; Mukwasi-Kahari C; Madanhire T; Kowo-Nyakoko F; McHugh G; Filteau S; Chipanga J; Simms V; Mujuru H; Ward KA; Ferrand RA; Gregson CL
    Lancet Child Adolesc Health; 2021 Aug; 5(8):569-581. PubMed ID: 34139202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
    Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in children and adolescents with perinatal HIV infection.
    DiMeglio LA; Wang J; Siberry GK; Miller TL; Geffner ME; Hazra R; Borkowsky W; Chen JS; Dooley L; Patel K; van Dyke RB; Fielding RA; Gurmu Y; Jacobson DL;
    AIDS; 2013 Jan; 27(2):211-20. PubMed ID: 23032412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
    Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
    Gregson CL; Hartley A; Majonga E; McHugh G; Crabtree N; Rukuni R; Bandason T; Mukwasi-Kahari C; Ward KA; Mujuru H; Ferrand RA
    Bone; 2019 Aug; 125():96-102. PubMed ID: 31082498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J; Viget N; Drumez E; Cortet B; Robineau O
    Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E; Szubert A; Otike C; Namyalo I; Nambi E; Bamford A; Doerholt K; Gibb DM; Musiime V; Musoke P
    PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
    AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
    Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
    AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.
    Jiménez B; Sainz T; Díaz L; Mellado MJ; Navarro ML; Rojo P; González-Tomé MI; Prieto L; Martínez J; de José MI; Ramos JT; Muñoz-Fernandez MÁ;
    Pediatr Infect Dis J; 2017 Jun; 36(6):578-583. PubMed ID: 28005690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
    AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
    Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.
    Pitukcheewanont P; Safani D; Church J; Gilsanz V
    Osteoporos Int; 2005 Nov; 16(11):1393-6. PubMed ID: 15702261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
    AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
    Rukuni R; Gregson C; Kahari C; Kowo F; McHugh G; Munyati S; Mujuru H; Ward K; Filteau S; Rehman AM; Ferrand R
    BMJ Open; 2020 Feb; 10(2):e031792. PubMed ID: 32041852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.